ANEUVO is hosting an educational session at ASCIP 2026 on Wednesday, September 9, featuring Sakina Valika, PT, DPT and Arjun Kumar, OTD discussing Transcutaneous Spinal Stimulation after Spinal Cord Injury.

Public source

Publisher name

Public post

Join us at ASCIP 2026 for an insightful educational session exploring the evolving role of non-invasive spinal stimulation in spinal cord injury rehabilitation. On Wedne…

Log in to read the full post

Company

ANEUVO

Pathways to New Horizons

Industry
Medical Equipment Manufacturing
Location
Los Angeles, us
Company size
11–50 employees

About ANEUVO

ANEUVO is a platform and therapy development company focused on treating disabling diseases and conditions that have not been curable through traditional pharmaceutical approaches. The ANEUVO ExaStim® Stimulation System is a non-invasive neuromodulation system for spinal cord injury which has received CE Mark approval and FDA 510(k) clearance in the United States. It is not commercially available outside these markets.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.